Public Policy Letters, Statements, Legal Briefs, & Other Responses

← Back to all Letters & Statements

  • ACMG Efforts Lead AMA Resolution 122 to Support Coverage of Medical Food Products
  • Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
  • ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage